HELP
Cybin Inc. Common Stock
通常取引データ（自動更新なし）RVOL 0.1xDV $3M20日平均DV $24M?
Earnings 2026-11-1252W high -0.3%52W low +218.9%Fwd PER 22.1xMarket cap $485MAvg volume 2.0M
Company Overview
Clinical-stage biopharmaceutical company developing psychedelic-based therapeutics including CYB003 (deuterated psilocybin analog) for major depressive disorder and CYB004 (deuterated DMT) for generalized anxiety disorder
Earnings & Financials
Earnings actuals
| Period | EPS | Revenue | FCF |
|---|
| 2026 Q1 | -0.89 | $0 | -$36M |
| 2026 Q4 | -0.92 | $0 | -$37M |
| 2025 Q3 | -1.76 | $0 | -$32M |
| 2025 Q2 | -1.94 | $0 | -$49M |
| 2025 Q1 | -1.10 | $0 | -$22M |
| 2025 Q4 | -1.46 | $0 | -$22M |
| 2024 Q3 |
